Introduction
Running a pharmaceutical wholesale business in the UK without the right authorisation isn't just risky, it's illegal. The Wholesale Distribution Authorisation (Human), known as a WDA(H), is the licence the MHRA requires before you procure, hold, supply or export human medicinal products on a wholesale basis.
Many businesses misunderstand its scope. Some assume a manufacturing licence covers wholesale activity automatically. Others believe small volumes or virtual operations sit outside the rules. Neither assumption holds up under Regulation 18 of the Human Medicines Regulations 2012.
This guide walks through eligibility, premises and personnel requirements, the application sequence, inspection expectations, costs and the compliance obligations that continue long after approval.
Key Takeaways
- A WDA(H) differs from a marketing authorisation, manufacturing licence, retail permission and controlled drugs licence
- MHRA evaluates your business model, named sites, Responsible Person and quality system before granting authorisation
- No universal minimum premises size exists; suitability depends on your actual product range and scale
- Fees and processing times change regularly; always confirm against current GOV.UK guidance
- Approval is the starting line, not the finish line; ongoing GDP compliance is mandatory
What Is a UK Wholesale Drug Licence and Why Is It Required?
A Wholesale Distribution Authorisation (Human), or WDA(H)—commonly called a wholesale dealer's licence—authorises specific wholesale distribution activities at named sites. It's issued by the MHRA under the Human Medicines Regulations 2012.
Wholesale distribution covers procuring, holding, supplying or exporting medicinal products, excluding direct supply to the patient. That last point trips up a lot of businesses that think retail-adjacent activity falls under the same rules.
How a WDA(H) Differs From Other Authorisations
These permissions sound similar but serve entirely different purposes:
- Marketing authorisation: permits a specific medicine to be marketed and sold
- Manufacturer's licence: covers making, assembling or importing medicines
- WDA(H): authorises the wholesale distribution activity at specified sites
Here's where it gets nuanced: a manufacturer's licence only exempts wholesale-dealing rules for products covered by that specific licence. If a manufacturer distributes other companies' products, or products outside its own authorisation, it typically needs a separate WDA(H) too.
Why This Licence Exists
The authorisation isn't red tape for its own sake. It supports:
- Product traceability through the supply chain
- Verified, approved sourcing routes
- Suitable storage and transport conditions
- Recall readiness when problems surface
- Protection against falsified or diverted medicines
Who Actually Needs One
Business models that typically fall within scope include:
- Traditional wholesalers and distributors
- Importers and exporters of human medicines
- Manufacturers supplying products beyond their own licensed range
- Virtual wholesalers, including those with no physical handling of stock
- Businesses using third-party logistics providers while retaining control of the transaction
Licensing depends on the activities performed and the control exercised, not simply on volume handled or who physically stores the products. A business that never touches a single box can still need a WDA(H) if it procures and supplies medicines commercially.
Requirements for a WDA(H)
Before submitting anything, MHRA expects a complete picture of your business, people and premises. Requirements shift over time, so always verify current forms against live MHRA guidance rather than relying on older summaries.
The Responsible Person
Every WDA(H) holder must name a Responsible Person (RP) with sufficient authority, knowledge and availability to oversee compliance. MHRA generally expects at least one year's practical experience in the authorised activities and one year managing a quality management system.
The RP's duties include:
- Maintaining GDP compliance across the operation
- Managing deviations, complaints and recalls
- Approving suppliers, customers and subcontracted activities
- Overseeing training and self-inspection schedules
Premises and Storage Controls
There's no fixed floor area requirement. What matters is suitability for your actual product range, stock levels and activities. Reviewers look for:
- Security and restricted access to storage areas
- Cleanliness and appropriate segregation of stock types
- Environmental conditions matched to product needs, including temperature mapping
- Clear arrangements for damaged, returned, recalled or quarantined stock
A generic warehouse description won't satisfy an inspector. The application needs to reflect the real operating environment, down to how cold-chain products are monitored.
Quality System Essentials
MHRA looks for a documented pharmaceutical quality system covering:
- Written SOPs and a quality manual
- Staff training records tied to specific roles
- Supplier and customer qualification procedures
- Complaints, recalls, deviations and CAPA processes
- Change control and document management
- A self-inspection schedule with defined methodology
Transport and Outsourced Activities
If you rely on third-party transport or logistics providers, expect to show:
- Signed contracts defining GDP responsibilities
- Risk assessments covering the outsourced activity
- Evidence the provider operates in line with GDP standards
- Ongoing oversight, not a one-off approval
Pre-application checklist:
- Corporate details and site plans
- Temperature-monitoring equipment records
- SOPs and training logs
- Responsible Person credentials
- Supporting evidence for supplier and customer qualification
Pull the latest forms directly from MHRA before compiling your file.
How to Apply for a WDA(H) in the UK
Applying isn't a single form submission. It's a sequence that starts well before you ever open the MHRA portal.
Step 1: Confirm Whether a WDA(H) Is Required
Map your activities against the legal definition of wholesale distribution:
- Procuring, holding or supplying
- Exporting or importing
- Brokering or virtual distribution
Brokering (negotiating on someone else's behalf without ever holding or supplying the product) generally sits outside WDA(H) scope. Mixed retail, manufacturing or group-company arrangements usually need case-specific review. Do not guess.
Step 2: Prepare the Organisation and Premises
Appoint your Responsible Person, build out GDP procedures, and get premises, staff and logistics arrangements genuinely inspection-ready. Submitting an aspirational application, one describing a system you haven't actually implemented, creates delays. Inspectors compare paperwork against reality.
Step 3: Submit the Application and Pay Current Fees
Applications go through MHRA's Process Licensing (PCL) portal. As of the current GOV.UK fee schedule, a standard initial application costs £6,295, covering a £2,159 application fee and £4,136 inspection fee.
| Fee Type | Cost |
|---|---|
| Standard initial application (with inspection) | £6,295 |
| Reduced application with full inspection | £5,128 |
| Reduced application, GSL-only | £3,060 |
| Periodic wholesale-dealer licence | £346 (or £206 reduced rate) |
| Standard variation | £652 |
| Administrative variation | £345 |
These figures change periodically. Never reuse a fee quoted in an older article or third-party blog without checking the live schedule first.
Step 4: Prepare for MHRA Assessment and Inspection
Inspectors examine premises, quality systems, staff understanding, temperature controls, supplier and customer qualification, and transport arrangements. If they flag deficiencies, you'll need evidence-based corrective and preventive actions. There's no guaranteed approval timeframe. MHRA's published guidance states applications "should take 90 working days," but that assumes a clean process.
Step 5: Receive, Review and Maintain the Authorisation
Once granted, your licence specifies approved sites, activities and product categories. Operating outside that scope isn't permitted. Any material change (new site, new activity or different RP) should trigger a review of whether a variation or notification is required.
Where the Licence Applies and How to Maintain Compliance
A WDA(H) attaches to named sites and approved activities, not to the business generically. Every location performing relevant wholesale operations needs to be assessed and, where required, named on the licence.
Recurring GDP Obligations
Holding the licence means maintaining these controls continuously:
- Sourcing only through approved supply chains
- Qualifying customers before supply
- Maintaining batch and transaction traceability
- Monitoring temperature and transport conditions
- Handling complaints, recalls and returns properly
- Escalating suspected counterfeit products immediately
- Running periodic self-audits and staff training Higher-risk activities such as controlled drugs, unusual order patterns, exports, or international customer supply often carry additional obligations. Controlled drug wholesalers, for instance, typically need a Home Office domestic licence alongside their WDA(H).
When Changes Trigger a Variation
Updates to premises, Responsible Person, product categories, ownership or outsourced providers can all require a variation or regulatory notification. Don't assume small changes are exempt; check first.
Verifying a Distributor's Licence
Before trading with a new supplier or customer, verify their status directly through MHRA's official register rather than trusting a certificate they hand you. Check the legal entity, site address, current status, approved activities and product categories. If you are also setting up in India alongside UK wholesale operations, VJM Global can support India entity registration, accounting and tax compliance. That work is separate from UK MHRA licensing and does not replace the WDA(H) process or specialist UK regulatory advice.
Common Issues and When a WDA(H) May Not Be Appropriate
A few misconceptions cause real problems for UK wholesale applicants.
Myth 1: Small volumes exempt you from licensing. They don't. The requirement hinges on activity type and control, not throughput.
Myth 2: Using a third-party warehouse shifts regulatory responsibility. It doesn't. You remain accountable for GDP compliance even when someone else physically holds your stock.
Myth 3: A manufacturing or marketing authorisation covers wholesale activity. It doesn't, except for the specific products on that licence—not everything else you might distribute.
Why Applications Stall or Fail
Even when a WDA(H) is the right permission, applications often stall for avoidable reasons:
- Premises that don't match the described operation
- Incomplete or generic SOPs
- Unclear accountability for the Responsible Person
- Weak temperature-monitoring evidence
- Inadequate supplier or customer qualification processes
- Operations exceeding the proposed licence scope
When You Need a Different Permission
Some activities call for something other than a WDA(H):
- Veterinary medicines require a separate veterinary wholesale authorisation
- Controlled drugs need an additional Home Office licence
- Manufacturing or importing requires an MIA, not a WDA(H)
- Pure retail supply typically falls under pharmacy regulation instead
If you only provide administrative, brokerage, or direct-to-patient services, do not default to a WDA(H). Map the real transaction and physical-flow model first, and take specialist advice where the boundary is unclear.
Regulatory disclaimer: requirements, fees, forms and processing times change. Confirm current details with the MHRA directly and seek professional advice for complex operating models.
Conclusion
Getting a UK wholesale drug licence means demonstrating that your business, people, premises and quality systems can protect medicinal product integrity from procurement through to final supply. That standard is an ongoing obligation, not a one-off filing.
Build your application around what you actually do and where you actually operate. Then treat GDP compliance as an ongoing discipline, not a box ticked at approval. Before preparing documents or starting wholesale operations, verify current MHRA requirements, fees and application routes directly. They shift more often than most guides admit.
Frequently Asked Questions
How much does a wholesale drug licence cost?
The current MHRA standard application fee is £6,295, including inspection costs. Total costs also include premises preparation, GDP system setup, Responsible Person arrangements and possibly consultancy support, so check the latest official fee schedule before budgeting.
How do I apply for a wholesale drug licence in the UK?
Confirm whether your activities meet the legal definition of wholesale distribution, then prepare your Responsible Person, premises and GDP quality system. Submit through MHRA's PCL portal with supporting evidence, and address any inspection findings promptly.
What are the requirements to obtain a wholesale distributor licence?
You need suitable premises, GDP-compliant procedures, a qualified Responsible Person and trained staff. You'll also need documented storage and transport controls, supplier and customer qualification processes, and full traceability records.
How long does it take to get MHRA approval?
MHRA states applications "should take" 90 working days, though this depends on application completeness, inspection findings and how quickly you respond to any deficiencies raised. Always check current MHRA guidance for the latest processing expectations.
What is the MHRA MIA licence and what are its requirements?
A Manufacturer's/Importer's Authorisation (MIA) covers manufacturing or importing specified medicinal products, distinct from wholesale distribution under a WDA(H). It carries its own premises, personnel, quality system and inspection requirements.
What is the minimum area required for a wholesale drug licence in the UK?
There's no fixed minimum floor area specified by MHRA. Premises must simply be appropriately sized and equipped for your specific products, stock levels, segregation needs and GDP controls.
